Plunkett Research Online: Vericel Corporation

VERICEL CORPORATION (VCEL:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vericel Corporation is a commercial-stage specialty biologics company. It develops patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. Vericel markets three U.S. FDA-approved autologous cell therapy products in the U.S.: Carticel, .....



Vericel Corporation
Ticker: VCEL
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone:
Fax:
Address: 64 Sidney Street
Cambridge, MA 02139 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
Regenerative medicine products
Clinical & Pre-clinical Development
ContactsDescription
Dominick ColangeloCEO/Director/President
Gerard MichelCFO/Chief Accounting Officer/Vice President, Divisional
See More
Vericel Corporation is a commercial-stage specialty biologics company. It develops patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. Vericel markets three U.S. FDA-approved autologous cell therapy products in the U.S.: Carticel, .....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor: Dykema Gossett
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Carticel
MACI
Epicel
ixmyelocel-T
ixCELL-DCM
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: